drugset / Trial / NCT05764733

Bone, Exercise, Alendronate, and Caloric Restriction

NCT05764733

RandomizedFactorialQuadruple-blindPrevention

Summary

The purpose of this research is to identify strategies that minimize bone loss that occurs when older adults lose weight. Participation in this research will involve up to nine assessment visits and last up to two years.

Timeline

Start
2023-06-08
Primary completion
2028-01
Completion
2028-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Alendronic Acid Small molecule 70 mg